Clinical Trial Update: PREFERENTIAL Study [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update shows the PREFERENTIAL study (Phase 2/3) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Glaucoma

Snippet

Sponsor: Duke University | Conditions: Cataract Surgery, Glaucoma Surgery | Phase 2, Phase 3 | Status: WITHDRAWN